HomeAI · summaries
Storia in 7 fonti
CNBC Daily Open: Generic problems, AI valuations and earnings on tap
President Trump takes fresh aim at the pharmaceutical sector, with a plan to levy 100% tariffs on generic drugs as he targets key areas ahead of the midterms.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
CNBC Daily Open: Trump revives his tariff playbook with Canada
U.S. President Donald Trump has revived his signature solution to many of his perceived problems: tariffs.
- ·
biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
- ·
CNBC Daily Open: AI race, potential tariffs and Middle East conflict continue to heat up
The U.S.-China AI race continues to intensify amid signs that the Trump administration could sanction China over "theft," while OpenAI ramps up IPO efforts.
- ·
thehindubusinessline.com
US to impose 100% tariffs on generic medicine imports from Aug 2028
US President Donald Trump on Wednesday announced steep tariffs on imported generic medicines from August 2028, asserting that the move was aimed at onshoring the manufacturing of…
- ·
CNBC Daily Open: Generic problems, AI valuations and earnings on tap
President Trump takes fresh aim at the pharmaceutical sector, with a plan to levy 100% tariffs on generic drugs as he targets key areas ahead of the midterms.
- ·
statnews.com
Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical manufacturing back to the U.S.
- ·
zerohedge.com
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
"For our generics coverage, we view the group as relatively well-positioned given: AMRX (significant US infrastructure), TEVA..."
- ·
fiercepharma.com
Trump floats countdown to 200% tariffs on generic drugs imported to US
While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. | While the White House focused…
- ·
cbsnews.com
Trump plans 100% tariffs on imported generic drugs. Here's what experts say.
Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.